Bluefin Capital Management’s Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares BIOX.WS Stock Holding History

Bluefin Capital Management’s Portfolio BIOX.WS Stock Details BIOX.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-123,184	Closed	-$26K	–	599
2020 Q2	$26K	Sell	123,184 -17,910	-13%	-$4.23K	﹤0.01%	328
2020 Q1	$20K	Sell	141,094 -58,623	-29%	-$9.65K	﹤0.01%	358
2019 Q4	$32K	Sell	199,717 -29,750	-13%	-$9.17K	﹤0.01%	486
2019 Q3	$78K	Buy	229,467 +1,600	+0.7%	+$607	0.01%	334
2019 Q2	$75K	Hold	227,867	–	–	0.01%	254
2019 Q1	$62K	Buy	+227,867	New	+$54.6K	0.01%	280

Bluefin Capital Management's BIOX.WS Position: Q3 2020 in Review

Bluefin Capital Management sold out of Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares (BIOX.WS) in Q3 2020, closing a stake of 123,184 shares — an estimated $26K sold.

Bluefin Capital Management first reported a position in BIOX.WS in Q1 2019 and held it in 6 quarters. The position peaked at $78K in Q3 2019. 0 funds tracked by Wall St. Rank hold BIOX.WS as of Q3 2020.

Bluefin Capital Management reported no remaining Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares position as of Q3 2020 after selling out during the quarter.
Bluefin Capital Management sold 123,184 Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares shares in Q3 2020, an estimated $26K.
Bluefin Capital Management first reported a position in Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares in Q1 2019 and held it in 6 quarters.
Bluefin Capital Management's Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares position peaked at $78K in Q3 2019.
0 funds tracked by Wall St. Rank held Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares as of Q3 2020.

Based on Bluefin Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.